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Abstract
© 2018 Shvedova, Anfinogenova, Atochina-Vasserman, Schepetkin and Atochin. In this article,
we review the literature regarding the role of c-Jun N-terminal kinases (JNKs) in cerebral and
myocardial  ischemia/reperfusion  injury.  Numerous  studies  demonstrate  that  JNK-mediated
signaling  pathways  play  an  essential  role  in  cerebral  and  myocardial  ischemia/reperfusion
injury. JNK-associated mechanisms are involved in preconditioning and post-conditioning of the
heart and the brain. The literature and our own studies suggest that JNK inhibitors may exert
cardioprotective and neuroprotective properties. The effects of modulating the JNK-depending
pathways  in  the  brain  and  the  heart  are  reviewed.  Cardioprotective  and  neuroprotective
mechanisms  of  JNK  inhibitors  are  discussed  in  detail  including  synthetic  small  molecule
inhibitors  (AS601245,  SP600125,  IQ-1S,  and  SR-3306),  ion  channel  inhibitor  GsMTx4,  JNK-
interacting proteins,  inhibitors  of  mixed-lineage kinase (MLK)  and MLK-interacting proteins,
inhibitors of glutamate receptors, nitric oxide (NO) donors, and anesthetics. The role of JNKs in
ischemia/reperfusion injury of  the heart in diabetes mellitus is  discussed in the context of
comorbidities. According to reviewed literature, JNKs represent promising therapeutic targets for
protection  of  the  brain  and  the  heart  against  ischemic  stroke  and  myocardial  infarction,
respectively.  However,  different  members  of  the  JNK  family  exert  diverse  physiological
properties which may not allow for systemic administration of non-specific JNK inhibitors for
therapeutic  purposes.  Currently  available  candidate  JNK  inhibitors  with  high  therapeutic
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